|Title:||Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β2-Agonist Combinations in Patients With COPD||Authors:||Chang, Ting-Yu
|Keywords:||COPD; acute exacerbation; inhaled corticosteroids; pneumonia||Issue Date:||May-2020||Publisher:||ELSEVIER||Journal Volume:||157||Journal Issue:||5||Start page/Pages:||1117||Source:||Chest||Abstract:||
The differential risk of pneumonia among inhaled corticosteroid (ICS) use in patients with COPD requires more investigation, especially regarding beclomethasone-containing inhalers. The goal of this study was to compare the risk and benefit profile of different ICS/long-acting β2-agonist (LABA) combinations in patients with COPD.
|Appears in Collections:||臨床藥學研究所|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.